Metabolic Characterization of Antifolate Responsiveness and Non-responsiveness in Malignant Pleural Mesothelioma Cells

Overview of attention for article published in Frontiers in Pharmacology, October 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter: 5 X users

Readers on

mendeley: 23 Mendeley

Summary X

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 46,508 followers.

7/n based on our hypothesis and observations by others (e.g. https://t.co/TY6JDjIZ6F) we ran a retrospective analysis and a small clinical trial that showed benefit of pemetrexed in patients with MTAP loss. https://t.co/ovfibh8LOt

30 Apr 2022

Reply Repost Favourite

Metabolic Characterization of Antifolate Responsiveness and Non-responsiveness in Malignant Pleural Mesothelioma Cells https://t.co/K8ivbAXchh

03 Nov 2018

Reply Repost Favourite

Metabolic Characterization of Antifolate Responsiveness and Non-responsiveness in Malignant Pleural Mesothelioma Cells https://t.co/ymlaISCCuU

02 Nov 2018

Reply Repost Favourite

RT @cpa61: Metabolic Characterization of Antifolate Responsiveness and Non-responsiveness in Malignant Pleural Mesothelioma Cells https://t…

20 Oct 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.